Aberrant β-catenin activation promotes tumor metastasis and angiogenesis (70–73), while β-catenin/TCF/LEF-dependent transcription, activated by the PI3K/AKT pathway, enhances VEGF-induced angiogenesis (74). This evidence concerns the gene AKT1 and neoplasm.